|
Status |
Public on Oct 10, 2013 |
Title |
Fundamental differences in promoter CpG island DNA hypermethylation between human cancer and genetically engineered mouse models of cancer |
Organisms |
Homo sapiens; Mus musculus |
Experiment type |
Methylation profiling by genome tiling array Methylation profiling by high throughput sequencing
|
Summary |
This SuperSeries is composed of the SubSeries listed below.
|
|
|
Overall design |
Refer to individual Series
|
|
|
Citation(s) |
24107773 |
Submission date |
Mar 20, 2013 |
Last update date |
May 15, 2019 |
Contact name |
Scott J. Diede |
E-mail(s) |
scott.diede@merck.com
|
Organization name |
Fred Hutchinson Cancer Research Center
|
Street address |
1100 Fairview Avenue North, Mailstop c3-168
|
City |
Seattle |
State/province |
WA |
ZIP/Postal code |
98109 |
Country |
USA |
|
|
Platforms (5)
|
GPL5082 |
[Hs_PromPR] Affymetrix Human Promoter 1.0R Array |
GPL5811 |
[Mm_PromPR] Affymetrix Mouse Promoter 1.0R Array |
GPL10999 |
Illumina Genome Analyzer IIx (Homo sapiens) |
GPL11002 |
Illumina Genome Analyzer IIx (Mus musculus) |
GPL13112 |
Illumina HiSeq 2000 (Mus musculus) |
|
Samples (31)
|
|
This SuperSeries is composed of the following SubSeries: |
GSE45240 |
Fundamental differences in promoter CpG island DNA hypermethylation between human cancer and genetically engineered mouse models of cancer [Methylation profiling by array] |
GSE45341 |
Fundamental differences in promoter CpG island DNA hypermethylation between human cancer and genetically engineered mouse models of cancer [RRBS] |
|
Relations |
BioProject |
PRJNA193499 |